196 filings
Page 4 of 10
10-K
2022 FY
NEXI
Neximmune Inc
Annual report
28 Mar 23
4:13pm
8-K
NEXI
Neximmune Inc
28 Mar 23
NexImmune Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
4:07pm
8-K
NEXI
Neximmune Inc
10 Mar 23
Regulation FD Disclosure
5:07pm
SC 13G/A
NEXI
Neximmune Inc
15 Feb 23
NexImmune / ArrowMark Colorado ownership change
12:00am
SC 13G/A
B&S NexImmune Holdco LLC
13 Feb 23
NexImmune / B&S NexImmune Holdco ownership change
4:16pm
SC 13G/A
NEXI
Neximmune Inc
13 Feb 23
NexImmune / BARER SOL J ownership change
4:16pm
SC 13G/A
NEXI
Neximmune Inc
13 Feb 23
NexImmune / Artal International S.C.A. ownership change
12:00am
4
Kristi Jones
29 Nov 22
NexImmune / Kristi Jones ownership change
5:09pm
4
John Trainer
25 Nov 22
NexImmune / John Trainer ownership change
5:05pm
4
NEXI
Neximmune Inc
25 Nov 22
NexImmune / MATHIAS OELKE ownership change
5:04pm
4
NEXI
Neximmune Inc
17 Nov 22
NexImmune / SOL J BARER ownership change
8:40pm
10-Q
2022 Q3
NEXI
Neximmune Inc
Quarterly report
14 Nov 22
4:38pm
8-K
NEXI
Neximmune Inc
14 Nov 22
NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update
4:11pm
8-K
NEXI
Neximmune Inc
28 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
10-Q
2022 Q2
NEXI
Neximmune Inc
Quarterly report
15 Aug 22
5:06pm
8-K
NEXI
Neximmune Inc
15 Aug 22
NexImmune Reports Second Quarter 2022 Financial Results and Highlights FDA Clearance of IND for NEXI-003 for the Treatment of HPV-Related Cancers
4:28pm
8-K
NEXI
Neximmune Inc
14 Jul 22
NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers
4:15pm
8-K
NEXI
Neximmune Inc
17 Jun 22
Entry into a Material Definitive Agreement
4:51pm
424B5
NEXI
Neximmune Inc
17 Jun 22
Prospectus supplement for primary offering
4:49pm
4
NEXI
Neximmune Inc
15 Jun 22
NexImmune / Timothy Bertram ownership change
5:01pm